A novel inhibitor of remyelination in multiple sclerosis: fibulin-2
A novel inhibitor of remyelination in multiple sclerosis: fibulin-2
多发性硬化症中髓鞘再生的新型抑制剂：fibulin-2
批准号：
440202
负责人：
Ghorbanigazar Samira
金额：
$9.83万
依托单位：
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2023-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple sclerosis (MS) is a disease in which the immune system destroys protective fatty protein (myelin) covering nerve fibers in the brain and spinal cord, leading to physical disability. A process by which myelin is reformed following injury called re
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
